A citation-based method for searching scientific literature

Christina Y Miyake, Gregory Webster, Richard J Czosek, Michal J Kantoch, Anne M Dubin, Kishor Avasarala, Joseph Atallah. Circ Arrhythm Electrophysiol 2013
Times Cited: 73







List of co-cited articles
1463 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.
Silvia G Priori, Arthur A Wilde, Minoru Horie, Yongkeun Cho, Elijah R Behr, Charles Berul, Nico Blom, Josep Brugada, Chern-En Chiang, Heikki Huikuri,[...]. Heart Rhythm 2013
61

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
Meiso Hayashi, Isabelle Denjoy, Fabrice Extramiana, Alice Maltret, Nathalie Roux Buisson, Jean-Marc Lupoglazoff, Didier Klug, Miyuki Hayashi, Seiji Takatsuki, Elisabeth Villain,[...]. Circulation 2009
310
57

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
Gaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, J Martijn Bos, Dominic J Abrams, Charles I Berul, Lia Crotti, Andrew M Davis, Michael Eldar, Maria Kharlap,[...]. Circulation 2015
156
47

Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.
Thomas M Roston, Jeffrey M Vinocur, Kathleen R Maginot, Saira Mohammed, Jack C Salerno, Susan P Etheridge, Mitchell Cohen, Robert M Hamilton, Andreas Pflaumer, Ronald J Kanter,[...]. Circ Arrhythm Electrophysiol 2015
136
45

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
Christian van der Werf, Prince J Kannankeril, Frederic Sacher, Andrew D Krahn, Sami Viskin, Antoine Leenhardt, Wataru Shimizu, Naokata Sumitomo, Frank A Fish, Zahurul A Bhuiyan,[...]. J Am Coll Cardiol 2011
250
42

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Ferran Roses-Noguer, Julian W E Jarman, Jonathan R Clague, Jan Till. Heart Rhythm 2014
68
45

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
S G Priori, C Napolitano, N Tiso, M Memmi, G Vignati, R Bloise, V Sorrentino, G A Danieli. Circulation 2001
940
36

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Silvia G Priori, Carlo Napolitano, Mirella Memmi, Barbara Colombi, Fabrizio Drago, Maurizio Gasparini, Luciano DeSimone, Fernando Coltorti, Raffaella Bloise, Roberto Keegan,[...]. Circulation 2002
753
36

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
A Leenhardt, V Lucet, I Denjoy, F Grau, D D Ngoc, P Coumel. Circulation 1995
615
34



Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.
Hiroshi Watanabe, Nagesh Chopra, Derek Laver, Hyun Seok Hwang, Sean S Davies, Daniel E Roach, Henry J Duff, Dan M Roden, Arthur A M Wilde, Björn C Knollmann. Nat Med 2009
385
28

Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Prince J Kannankeril, Jeremy P Moore, Marina Cerrone, Silvia G Priori, Naomi J Kertesz, Pamela S Ro, Anjan S Batra, Elizabeth S Kaufman, David L Fairbrother, Elizabeth V Saarel,[...]. JAMA Cardiol 2017
75
28

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.
Arthur A M Wilde, Zahurul A Bhuiyan, Lia Crotti, Mario Facchini, Gaetano M De Ferrari, Thomas Paul, Chiara Ferrandi, Dave R Koolbergen, Attilio Odero, Peter J Schwartz. N Engl J Med 2008
277
27

Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.
Thomas M Roston, Karolina Jones, Nathaniel M Hawkins, J Martijn Bos, Peter J Schwartz, Frances Perry, Michael J Ackerman, Zachary W M Laksman, Padma Kaul, Krystien V V Lieve,[...]. Heart Rhythm 2018
42
47

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
Christian van der Werf, Krystien V Lieve, J Martijn Bos, Conor M Lane, Isabelle Denjoy, Ferran Roses-Noguer, Takeshi Aiba, Yuko Wada, Jodie Ingles, Ida S Leren,[...]. Eur Heart J 2019
50
40

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.
H Lahat, E Pras, T Olender, N Avidan, E Ben-Asher, O Man, E Levy-Nissenbaum, A Khoury, A Lorber, B Goldman,[...]. Am J Hum Genet 2001
450
24

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
Mette Nyegaard, Michael T Overgaard, Mads T Søndergaard, Marta Vranas, Elijah R Behr, Lasse L Hildebrandt, Jacob Lund, Paula L Hedley, A John Camm, Göran Wettrell,[...]. Am J Hum Genet 2012
236
21


Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
Christian van der Werf, Ineke Nederend, Nynke Hofman, Nan van Geloven, Corné Ebink, Ingrid M E Frohn-Mulder, A Marco W Alings, Hans A Bosker, Frank A Bracke, Freek van den Heuvel,[...]. Circ Arrhythm Electrophysiol 2012
98
21

Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
Hiroshi Watanabe, Christian van der Werf, Ferran Roses-Noguer, Arnon Adler, Naokata Sumitomo, Christian Veltmann, Raphael Rosso, Zahurul A Bhuiyan, Hennie Bikker, Prince J Kannankeril,[...]. Heart Rhythm 2013
57
28

Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.
Stephen Pizzale, Michael H Gollob, Robert Gow, David H Birnie. J Cardiovasc Electrophysiol 2008
64
23

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.
Nathalie Roux-Buisson, Marine Cacheux, Anne Fourest-Lieuvin, Jeremy Fauconnier, Julie Brocard, Isabelle Denjoy, Philippe Durand, Pascale Guicheney, Florence Kyndt, Antoine Leenhardt,[...]. Hum Mol Genet 2012
162
20

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
Raymond W Sy, Michael H Gollob, George J Klein, Raymond Yee, Allan C Skanes, Lorne J Gula, Peter Leong-Sit, Robert M Gow, Martin S Green, David H Birnie,[...]. Heart Rhythm 2011
116
20

Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
Peter J Schwartz, Carla Spazzolini, Silvia G Priori, Lia Crotti, Alessandro Vicentini, Maurizio Landolina, Maurizio Gasparini, Arthur A M Wilde, Reinoud E Knops, Isabelle Denjoy,[...]. Circulation 2010
182
20


Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders.
J Martijn Bos, Katy M Bos, Jonathan N Johnson, Christopher Moir, Michael J Ackerman. Circ Arrhythm Electrophysiol 2013
73
17

Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
Peter J Schwartz, Silvia G Priori, Marina Cerrone, Carla Spazzolini, Attilio Odero, Carlo Napolitano, Raffaella Bloise, Gaetano M De Ferrari, Catherine Klersy, Arthur J Moss,[...]. Circulation 2004
434
17

High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
G Michael Vincent, Peter J Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain,[...]. Circulation 2009
192
16

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
N Sumitomo, K Harada, M Nagashima, T Yasuda, Y Nakamura, Y Aragaki, A Saito, K Kurosaki, K Jouo, M Koujiro,[...]. Heart 2003
242
15

Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study.
Joseph Atallah, Christopher C Erickson, Frank Cecchin, Anne M Dubin, Ian H Law, Mitchell I Cohen, Martin J Lapage, Bryan C Cannon, Terrence U H Chun, Vicki Freedenberg,[...]. Circulation 2013
111
15

Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
A J Moss, W Zareba, W J Hall, P J Schwartz, R S Crampton, J Benhorin, G M Vincent, E H Locati, S G Priori, C Napolitano,[...]. Circulation 2000
541
15

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Sana M Al-Khatib, William G Stevenson, Michael J Ackerman, William J Bryant, David J Callans, Anne B Curtis, Barbara J Deal, Timm Dickfeld, Michael E Field, Gregg C Fonarow,[...]. J Am Coll Cardiol 2018
197
15

2018 ESC Guidelines for the diagnosis and management of syncope.
Michele Brignole, Angel Moya, Frederik J de Lange, Jean-Claude Deharo, Perry M Elliott, Alessandra Fanciulli, Artur Fedorowski, Raffaello Furlan, Rose Anne Kenny, Alfonso Martín,[...]. Eur Heart J 2018
562
15

2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.
Jonathan S Steinberg, Niraj Varma, Iwona Cygankiewicz, Peter Aziz, Paweł Balsam, Adrian Baranchuk, Daniel J Cantillon, Polychronis Dilaveris, Sergio J Dubner, Nabil El-Sherif,[...]. Heart Rhythm 2017
97
15

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Rafael Rosso, Jonathan M Kalman, Ori Rogowski, Shmuel Diamant, Amir Birger, Simon Biner, Bernard Belhassen, Sami Viskin. Heart Rhythm 2007
113
13

Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.
Alex V Postma, Isabelle Denjoy, Theo M Hoorntje, Jean-Marc Lupoglazoff, Antoine Da Costa, Pascale Sebillon, Marcel M A M Mannens, Arthur A M Wilde, Pascale Guicheney. Circ Res 2002
290
13

Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus.
Katja Zeppenfeld, Martin J Schalij, Margot M Bartelings, Usha B Tedrow, Bruce A Koplan, Kyoko Soejima, William G Stevenson. Circulation 2007
196
13

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Gust H Bardy, Kerry L Lee, Daniel B Mark, Jeanne E Poole, Douglas L Packer, Robin Boineau, Michael Domanski, Charles Troutman, Jill Anderson, George Johnson,[...]. N Engl J Med 2005
13

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Michael J Ackerman, Silvia G Priori, Stephan Willems, Charles Berul, Ramon Brugada, Hugh Calkins, A John Camm, Patrick T Ellinor, Michael Gollob, Robert Hamilton,[...]. Europace 2011
482
13


The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.
Mark L Bannister, N Lowri Thomas, Markus B Sikkel, Saptarshi Mukherjee, Chloe Maxwell, Kenneth T MacLeod, Christopher H George, Alan J Williams. Circ Res 2015
62
16


The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Argelia Medeiros-Domingo, Zahurul A Bhuiyan, David J Tester, Nynke Hofman, Hennie Bikker, J Peter van Tintelen, Marcel M A M Mannens, Arthur A M Wilde, Michael J Ackerman. J Am Coll Cardiol 2009
204
12



Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study.
Paul Khairy, Michael J Landzberg, Michael A Gatzoulis, Hugues Lucron, Jean Lambert, François Marçon, Mark E Alexander, Edward P Walsh. Circulation 2004
234
12


Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
Asaad Khoury, Ibrahim Marai, Mahmoud Suleiman, Miry Blich, Avraham Lorber, Lior Gepstein, Monther Boulos. Heart Rhythm 2013
35
25

The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.
Miyuki Hayashi, Isabelle Denjoy, Meiso Hayashi, Fabrice Extramiana, Alice Maltret, Nathalie Roux-Buisson, Jean-Marc Lupoglazoff, Didier Klug, Philippe Maury, Anne Messali,[...]. Europace 2012
36
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.